CStone Pharmaceuticals (HKG:2616)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.190
-0.160 (-3.68%)
Jul 30, 2026, 4:08 PM HKT

CStone Pharmaceuticals Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-437-91.21-367.23-902.68-1,920
Depreciation & Amortization
43.9149.7456.9342.0320.06
Other Amortization
0.070.071.272.512.6
Loss (Gain) From Sale of Assets
--0.38-178.89-0.9
Asset Writedown & Restructuring Costs
16.810.7326.423.41-
Loss (Gain) From Sale of Investments
2.63-6.01-0.0662.0364.21
Stock-Based Compensation
23.97-2.8136.99142.06222.67
Other Operating Activities
94.81-2.31-26.8-54.4885.93
Change in Accounts Receivable
50.1288.48-95.3140.47-117.6
Change in Inventory
81.99-174.9-95.4630.42-86.18
Change in Accounts Payable
-202.98-170.1-121.6-3.1153.08
Change in Unearned Revenue
-3570--6.76
Change in Other Net Operating Assets
-2.05-39.51104.926.5997.17
Operating Cash Flow
-327.75-303.21-588.84-610.74-1,484
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
---0.02--91.03
Sale of Property, Plant & Equipment
-0.410.11--
Sale (Purchase) of Intangibles
--151.57-101.82-58.11
Investment in Securities
123.46-254.13447.69463.81-687.48
Other Investing Activities
10.536.0520.251.4110.06
Investing Cash Flow
133.99-247.68619.61363.39-826.55

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
265278350113.0496.22
Long-Term Debt Repaid
-273.14-312.02-289.98-75.3-18.5
Net Debt Issued (Repaid)
-8.14-34.0260.0237.7577.72
Issuance of Common Stock
672.460.07341.822.5316.83
Other Financing Activities
-86.54-18.92-13.49-11.81-2.24
Financing Cash Flow
577.78-52.86388.3628.4792.3

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-18.26-4.9818.8734.84-63.55
Net Cash Flow
365.76-608.73437.99-184.04-2,282

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-327.75-303.21-588.86-610.74-1,575
Free Cash Flow Growth
-----
Free Cash Flow Margin
-121.58%-74.46%-126.95%-126.88%-646.26%
Free Cash Flow Per Share
-0.24-0.24-0.47-0.52-1.35
Levered Free Cash Flow
-251.06-233.08-495.11-398.41-1,054
Unlevered Free Cash Flow
-242.77-223.6-487.73-393.11-1,052

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
10.8811.910.1811.812.24
Cash Income Tax Paid
13.06----
Change in Working Capital
-72.93-261.03-137.4574.3739.7